CME Group logo

CME Group (CME) Q3 2024 Earnings

CME·Reported October 23, 2024·Before market open

CME Group reported Q3 2024 revenue of $1.6B, missed analyst consensus of $1.6B by $4.3M. Diluted EPS came in at $2.68, beat the $2.66 consensus by $0.02. CME Group reports across 4 business segments, led by Derivatives Exchange, Clearing Services, and Cash Markets.

Revenue
$1.6Bmissed by $4.3M
Consensus: $1.6B
Diluted EPS
$2.68beat by $0.02
Consensus: $2.66
SEC

SEC Filings

Earnings release8-K not filed yet

Financial Snapshot

Trailing eight quarters through Q3 2024

Net Income

View metric

Operating Cash Flow

View metric

EPS (Diluted)

View metric

Q3 2024 Earnings FAQ

Common questions about CME Group's Q3 2024 earnings report.

CME Group (CME) reported Q3 2024 earnings on October 23, 2024 before market open.

CME Group reported revenue of $1.6B and diluted EPS of $2.68 for Q3 2024.

Revenue missed the consensus estimate of $1.6B by $4.3M. EPS beat the consensus estimate of $2.66 by $0.02.

You can read the 10-Q periodic report (0001156375-24-000200) directly on SEC EDGAR. The filing index links above go to sec.gov.